Literature DB >> 2153518

Advancing age results in reduction of intestinal and bone 1,25-dihydroxyvitamin D receptor.

R L Horst1, J P Goff, T A Reinhardt.   

Abstract

Target tissue 1,25-dihydroxyvitamin D [1,25-(OH)2D] receptor was monitored in adult (15- to 18-month-old) and young (4- to 5-week-old) male Holtzman rats. The concentration of unoccupied receptor (femtomoles per mg protein) was significantly higher in the intestine (666 +/- 19 vs. 162 +/- 43) and bone (61 +/- 3.7 vs. 18 +/- 2.5) of young rats compared to that in adults. The dissociation constant (Kd) of the intestinal receptor, however, remained very similar at both ages (young, 0.24 nM; adult, 0.53 nM). A similar age-related decline in unoccupied intestinal receptor was also observed in Fischer 344 rats and cows. Infusion of young and adult Holtzman rats with about 72 ng/kg BW 1,25-(OH)2D3 resulted in similar changes in the concentrations of plasma 1,25-(OH)2D3 (150-160 pg/ml) in both age groups. The 1,25-(OH)2D3 infusions also resulted in significant up-regulation of unoccupied intestinal receptor (femtomoles per mg protein) from 512 +/- 27 to 780 +/- 61 in the young rats and 68 +/- 9.4 to 194 +/- 15 in the adult rats. Receptor up-regulation by 1,25-(OH)2D3 (change from control) was significantly higher (P less than 0.05) in young rats (268 +/- 51 fmol/mg protein) than in adults (125 +/- 8.2 fmol/mg protein). These data suggest that the differences in receptor number in young and adult rats may be responsible for functional changes in target tissue response to 1,25-(OH)2D3 associated with advancing age.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2153518     DOI: 10.1210/endo-126-2-1053

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  28 in total

Review 1.  Relevance of vitamin D in muscle health.

Authors:  Heike A Bischoff-Ferrari
Journal:  Rev Endocr Metab Disord       Date:  2012-03       Impact factor: 6.514

2.  Intestinal resistance to 1,25 dihydroxyvitamin D in mice heterozygous for the vitamin D receptor knockout allele.

Authors:  Yurong Song; James C Fleet
Journal:  Endocrinology       Date:  2006-11-16       Impact factor: 4.736

3.  Superiority of alfacalcidol compared to vitamin D plus calcium in lumbar bone mineral density in postmenopausal osteoporosis.

Authors:  R Nuti; G Bianchi; M L Brandi; R Caudarella; E D'Erasmo; C Fiore; G C Isaia; G Luisetto; M Muratore; P Oriente; S Ortolani
Journal:  Rheumatol Int       Date:  2005-11-10       Impact factor: 2.631

4.  Long-term culture in dexamethasone unmasks an abnormal phenotype in osteoblasts isolated from osteoporotic subjects.

Authors:  L G Rao; T M Murray; J N Wylie; R J McBroom; M Kung Sutherland
Journal:  J Endocrinol Invest       Date:  2005-11       Impact factor: 4.256

5.  Suppression of the osteogenic response in the aging skeleton.

Authors:  C T Rubin; S D Bain; K J McLeod
Journal:  Calcif Tissue Int       Date:  1992-04       Impact factor: 4.333

Review 6.  Mechanisms of age-related endocrine alterations. Part II.

Authors:  A D Mooradian
Journal:  Drugs Aging       Date:  1993 Mar-Apr       Impact factor: 3.923

7.  Age- and gender-related changes in the distribution of osteocalcin in the extracellular matrix of normal male and female bone. Possible involvement of osteocalcin in bone remodeling.

Authors:  R T Ingram; Y K Park; B L Clarke; L A Fitzpatrick
Journal:  J Clin Invest       Date:  1994-03       Impact factor: 14.808

8.  Impact of age on survival predictability of bone turnover markers in hemodialysis patients.

Authors:  Paungpaga Lertdumrongluk; Wei Ling Lau; Jongha Park; Connie M Rhee; Csaba P Kovesdy; Kamyar Kalantar-Zadeh
Journal:  Nephrol Dial Transplant       Date:  2013-07-30       Impact factor: 5.992

Review 9.  Is there a role for vitamin D in osteoporosis?

Authors:  C Lamberg-Allardt
Journal:  Calcif Tissue Int       Date:  1991       Impact factor: 4.333

Review 10.  Vitamin D and aging.

Authors:  J Christopher Gallagher
Journal:  Endocrinol Metab Clin North Am       Date:  2013-04-09       Impact factor: 4.741

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.